NTMir’s mission is to save and improve lives through research, education, early detection, and improved treatments for people with pulmonary nontuberculous mycobacterial (NTM) disease.

Latest News

View More

ATS/PAR Meet the Experts

The American Thoracic Society Public Advisory Roundtable (ATS/PAR) is proud to present their 12th Annual “Meet the Experts” Patient/Family Forum at the Manchester Grand Hyatt Hotel on...
Read More

Registration Now Open for 2018 Conference!

We hope to see you at the 2018 NTM & Bronchiectasis Physician/Patient Conference, to be held on May 17, 2018 at the Estancia La Jolla Hotel in...
Read More

UPDATE: FDA Decision on Linhaliq

Aradigm, the company that submitted Linhaliq to the FDA for approval, announced that they had received a complete response letter (CRL) from the FDA stating that they...
Read More

Corporate Sponsor

Stay Informed

Sign up for NTMir's news releases